# A Study to Assess the Use of Methylone in the Treatment of PTSD

> **NCT05741710** · PHASE1,PHASE2 · COMPLETED · sponsor: **Transcend Therapeutics** · enrollment: 79 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Methylone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05741710
- **Lead sponsor:** Transcend Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-02-19
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05741710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05741710, "A Study to Assess the Use of Methylone in the Treatment of PTSD". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05741710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*